1. Home
  2. HSIC vs LNTH Comparison

HSIC vs LNTH Comparison

Compare HSIC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

HOLD

Current Price

$84.83

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$100.61

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSIC
LNTH
Founded
1932
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
6.6B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
HSIC
LNTH
Price
$84.83
$100.61
Analyst Decision
Buy
Buy
Analyst Count
16
6
Target Price
$85.07
$87.00
AVG Volume (30 Days)
834.0K
962.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
7.21
N/A
EPS
1.74
2.91
Revenue
$13,201,995,000.00
$343,374,000.00
Revenue This Year
$6.12
N/A
Revenue Next Year
$3.64
$14.19
P/E Ratio
$48.87
$34.64
Revenue Growth
5.94
3.62
52 Week Low
$61.97
$49.67
52 Week High
$92.18
$111.86

Technical Indicators

Market Signals
Indicator
HSIC
LNTH
Relative Strength Index (RSI) 36.83 48.37
Support Level $82.77 $100.51
Resistance Level $88.78 $101.43
Average True Range (ATR) 1.74 0.44
MACD -0.59 0.10
Stochastic Oscillator 13.79 49.80

Price Performance

Historical Comparison
HSIC
LNTH

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: